2335 GMT - Cochlear's bull at Canaccord Genuity sees nothing in its operations to justify the size of the selloff that followed the hearing-tech provider's 1H profit miss. Analyst Shane Storey keeps a buy rating on the Australia-listed stock, telling clients in a note that a 19% share-price fall seems extreme on a 5% net profit miss. Shareholder emotion and frustration are the only reasons he can give to explain the drop. Storey observes that the selloff took the company's earnings multiple to a 10-year low and sees this as a buying opportunity that echoes one sparked in 2011 by a product recall. Canaccord Genuity cuts its target price 11% to A$295.00. Shares are up 2.7% at A$204.68. (stuart.condie@wsj.com)
(END) Dow Jones Newswires
February 15, 2026 18:35 ET (23:35 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.